This grant, offered by NCI, NIDA, and NCCIH, is for prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients undergoing active treatment. The purpose is to fund well-designed prospective cohort studies comparing cannabis/cannabinoid users with non-users among patients with solid or hematologic tumors. The departments strongly encourage applications that include diverse populations by age, sex, race/ethnicity, tumor types, and geography, utilizing population-based recruitment strategies like cancer registries. Funded studies will collaborate with a dedicated coordinating center and NIH program staff to advance understanding in this critical area of cancer care.
Opportunity ID: 343905
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-052 |
| Funding Opportunity Title: | Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 03, 2022 |
| Last Updated Date: | Oct 03, 2022 |
| Original Closing Date for Applications: | Feb 17, 2023 |
| Current Closing Date for Applications: | Feb 17, 2023 |
| Archive Date: | Mar 25, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education County governments Native American tribal governments (Federally recognized) Independent school districts Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments For profit organizations other than small businesses City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Funding Opportunity Announcement (FOA), NCI, NIDA, and NCCIH invite Cooperative Agreement (U01) applications that propose prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients during active treatment. NCI, NIDA, and NCCIH are seeking well-designed prospective cohort studies of cancer patients with solid or hematologic tumors currently receiving treatment. Studies are expected to compare cancer patients who use cannabis/cannabinoids with cancer patients that do not use cannabis and/or cannabinoids. Research studies including diverse populations by age, sex, race/ethnicity, tumor types, and/or geography and propose population-based recruitment strategies using cancer registries are strongly encouraged. This FOA is published in parallel with RFA-CA-22-053 “Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed). New prospective studies and the coordinating center funded under these FOAs will work together with NIH program staff. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-052.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 343905 Full Announcement-RFA-CA-22-052 -> RFA-CA-22-052-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277977 | Jan 17, 2023 | Feb 17, 2023 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00277125 | Jan 17, 2023 | Jan 24, 2023 | View |
Package 1
Mandatory forms
343905 RR_SF424_5_0-5.0.pdf
343905 PHS398_CoverPageSupplement_5_0-5.0.pdf
343905 RR_OtherProjectInfo_1_4-1.4.pdf
343905 PerformanceSite_4_0-4.0.pdf
343905 RR_KeyPersonExpanded_4_0-4.0.pdf
343905 PHS398_ResearchPlan_5_0-5.0.pdf
343905 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343905 RR_Budget_3_0-3.0.pdf
343905 RR_SubawardBudget30_3_0-3.0.pdf
343905 PHS398_ModularBudget_1_2-1.2.pdf
343905 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343905 RR_SF424_5_0-5.0.pdf
343905 PHS398_CoverPageSupplement_5_0-5.0.pdf
343905 RR_OtherProjectInfo_1_4-1.4.pdf
343905 PerformanceSite_4_0-4.0.pdf
343905 RR_KeyPersonExpanded_4_0-4.0.pdf
343905 PHS398_ResearchPlan_4_0-4.0.pdf
343905 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343905 RR_Budget_3_0-3.0.pdf
343905 RR_SubawardBudget30_3_0-3.0.pdf
343905 PHS398_ModularBudget_1_2-1.2.pdf
343905 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
